Beyond Just Peptide Antigens: The Complex World of Peptide-Based Cancer Vaccines
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Beyond Just Peptide Antigens: The Complex World of Peptide-Based Cancer Vaccines
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-06-30
DOI
10.3389/fimmu.2021.696791
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Advances in the development of personalized neoantigen-based therapeutic cancer vaccines
- (2021) Eryn Blass et al. Nature Reviews Clinical Oncology
- mRNA vaccine for cancer immunotherapy
- (2021) Lei Miao et al. Molecular Cancer
- Mixed 20-peptide cancer vaccine in combination with docetaxel and dexamethasone for castration-resistant prostate cancer: a randomized phase II trial
- (2020) Masanori Noguchi et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Peptide–TLR-7/8a conjugate vaccines chemically programmed for nanoparticle self-assembly enhance CD8 T-cell immunity to tumor antigens
- (2020) Geoffrey M. Lynn et al. NATURE BIOTECHNOLOGY
- Revisiting the role of CD4+ T cells in cancer immunotherapy—new insights into old paradigms
- (2020) Rong En Tay et al. CANCER GENE THERAPY
- Nanoliposomal vaccine containing long multi-epitope peptide E75-AE36 pulsed PADRE-induced effective immune response in mice TUBO model of breast cancer
- (2020) Parvin Zamani et al. EUROPEAN JOURNAL OF CANCER
- Serum IL6 as a Prognostic Biomarker and IL6R as a Therapeutic Target in Biliary Tract Cancers
- (2020) Dan Høgdall et al. CLINICAL CANCER RESEARCH
- Cancer vaccines: designing artificial synthetic long peptides to improve presentation of class I and class II T cell epitopes by dendritic cells
- (2019) Catherine Rabu et al. OncoImmunology
- CAR T-cells: costs, comparisons, and commentary
- (2019) Annette E. Hay et al. JOURNAL OF MEDICAL ECONOMICS
- Regulation of the translation activity of antigen-specific mRNA is responsible for antigen loss and tumor immune escape in a HER2-expressing tumor model
- (2019) Baek-Sang Han et al. Scientific Reports
- Optimization of peptide-based cancer vaccine compositions, by sequential screening, using versatile liposomal platform
- (2019) Célia Jacoberger-Foissac et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Prevention and treatment of cervical cancer by a single administration of human papillomavirus peptide vaccine with CpG oligodeoxynucleotides as an adjuvant in vivo
- (2019) Yang Yang et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Cell-Penetrating Peptide Enhanced Antigen Presentation for Cancer Immunotherapy
- (2019) Hanfei Wu et al. BIOCONJUGATE CHEMISTRY
- MPL nano-liposomal vaccine containing P5 HER2/neu-derived peptide pulsed PADRE as an effective vaccine in a mice TUBO model of breast cancer
- (2019) Parvin Zamani et al. JOURNAL OF CONTROLLED RELEASE
- Comprehensive Evaluation of the Expressed CD8+ T Cell Epitope Space Using High-Throughput Epitope Mapping
- (2019) Paul V. Lehmann et al. Frontiers in Immunology
- T Cell Dysfunction in Cancer Immunity and Immunotherapy
- (2019) Anliang Xia et al. Frontiers in Immunology
- Potentiation of Kras peptide cancer vaccine by avasimibe, a cholesterol modulator
- (2019) Jing Pan et al. EBioMedicine
- Cationic synthetic long peptides-loaded nanogels: An efficient therapeutic vaccine formulation for induction of T-cell responses
- (2019) Neda Kordalivand et al. JOURNAL OF CONTROLLED RELEASE
- Reduction of MHC-I expression limits T-lymphocyte-mediated killing of Cancer-initiating cells
- (2018) Brian J. Morrison et al. BMC CANCER
- Personalized cancer vaccines: adjuvants are important, too
- (2018) Cécile Gouttefangeas et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Peptide Vaccine Formulation Controls the Duration of Antigen Presentation and Magnitude of Tumor-Specific CD8+T Cell Response
- (2018) Hiep Khong et al. JOURNAL OF IMMUNOLOGY
- mRNA vaccines — a new era in vaccinology
- (2018) Norbert Pardi et al. NATURE REVIEWS DRUG DISCOVERY
- Preclinical development of peptide vaccination combined with oncolytic MG1-E6E7 for HPV-associated cancer
- (2018) Matthew J. Atherton et al. VACCINE
- Trial watch: peptide-based vaccines in anticancer therapy
- (2018) Lucillia Bezu et al. OncoImmunology
- Smart pH-Sensitive Nanogels for Controlled Release in an Acidic Environment
- (2018) Peng Wei et al. BIOMACROMOLECULES
- DNA Vaccines—How Far From Clinical Use?
- (2018) Dominika Hobernik et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Actively personalized vaccination trial for newly diagnosed glioblastoma
- (2018) Norbert Hilf et al. NATURE
- Novel TLR2-binding adjuvant induces enhanced T cell responses and tumor eradication
- (2018) Gijs G. Zom et al. Journal for ImmunoTherapy of Cancer
- High Therapeutic Efficacy of a New Survivin LSP-Cancer Vaccine Containing CD4+ and CD8+ T-Cell Epitopes
- (2018) Fanny Onodi et al. Frontiers in Oncology
- Effect of TLR ligands co-encapsulated with multiepitopic antigen in nanoliposomes targeted to human DCs via Fc receptor for cancer vaccines
- (2017) Felix Rueda et al. IMMUNOBIOLOGY
- Myeloid-derived suppressor cells and T regulatory cells in tumors: unraveling the dark side of the force
- (2017) Aikaterini Hatziioannou et al. JOURNAL OF LEUKOCYTE BIOLOGY
- A Novel DNA Vaccine Platform Enhances Neo-antigen-like T Cell Responses against WT1 to Break Tolerance and Induce Anti-tumor Immunity
- (2017) Jewell N. Walters et al. MOLECULAR THERAPY
- An immunogenic personal neoantigen vaccine for patients with melanoma
- (2017) Patrick A. Ott et al. NATURE
- Mechanisms and Dynamics of T Cell-Mediated Cytotoxicity In Vivo
- (2017) Stephan Halle et al. TRENDS IN IMMUNOLOGY
- Protective cellular immunity generated by cross-presenting recombinant overlapping peptide proteins
- (2017) Lili Cai et al. Oncotarget
- Liposomal vaccine formulations as prophylactic agents: design considerations for modern vaccines
- (2017) Luis O. De Serrano et al. JOURNAL OF NANOBIOTECHNOLOGY
- Fundamentals and Methods for T- and B-Cell Epitope Prediction
- (2017) Jose L. Sanchez-Trincado et al. Journal of Immunology Research
- Toxicities of chimeric antigen receptor T cells: recognition and management
- (2016) Jennifer N. Brudno et al. BLOOD
- Basics of PD-1 in self-tolerance, infection, and cancer immunity
- (2016) Shunsuke Chikuma International Journal of Clinical Oncology
- Synthetic long peptide-based vaccine formulations for induction of cell mediated immunity: A comparative study of cationic liposomes and PLGA nanoparticles
- (2016) Eleni Maria Varypataki et al. JOURNAL OF CONTROLLED RELEASE
- Pathogen-Associated Molecular Patterns Induced Crosstalk between Dendritic Cells, T Helper Cells, and Natural Killer Helper Cells Can Improve Dendritic Cell Vaccination
- (2016) Tammy Oth et al. MEDIATORS OF INFLAMMATION
- Potentiating the antitumour response of CD8+ T cells by modulating cholesterol metabolism
- (2016) Wei Yang et al. NATURE
- TLR2 ligand-synthetic long peptide conjugates effectively stimulate tumor-draining lymph node T cells of cervical cancer patients
- (2016) Gijs G. Zom et al. Oncotarget
- Optimization of Peptide Vaccines to Induce Robust Antitumor CD4 T-cell Responses
- (2016) Takumi Kumai et al. Cancer Immunology Research
- A novel dendritic cell targeting HPV16 E7 synthetic vaccine in combination with PD-L1 blockade elicits therapeutic antitumor immunity in mice
- (2016) Zhida Liu et al. OncoImmunology
- Adjuvants for peptide-based cancer vaccines
- (2016) Hiep Khong et al. Journal for ImmunoTherapy of Cancer
- Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
- (2015) Suzanne L. Topalian et al. CANCER CELL
- Potency of Both Human Th1 and NK Helper Cell Activation is Determined by IL-12p70-Producing PAMP-Matured DCs
- (2015) Tammy Oth et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Sequence-engineered mRNA Without Chemical Nucleoside Modifications Enables an Effective Protein Therapy in Large Animals
- (2015) Andreas Thess et al. MOLECULAR THERAPY
- Cell-Type Specific Penetrating Peptides: Therapeutic Promises and Challenges
- (2015) Maliha Zahid et al. MOLECULES
- Adoptive cell transfer as personalized immunotherapy for human cancer
- (2015) S. A. Rosenberg et al. SCIENCE
- Liposome-based Formulation for Intracellular Delivery of Functional Proteins
- (2015) Benoît Chatin et al. Molecular Therapy-Nucleic Acids
- Strategic Approaches to Optimizing Peptide ADME Properties
- (2014) Li Di AAPS Journal
- New insights into cancer immunoediting and its three component phases—elimination, equilibrium and escape
- (2014) Deepak Mittal et al. CURRENT OPINION IN IMMUNOLOGY
- Dendritic cell maturation: functional specialization through signaling specificity and transcriptional programming
- (2014) M. Dalod et al. EMBO JOURNAL
- Mannose derivative and lipid A dually decorated cationic liposomes as an effective cold chain free oral mucosal vaccine adjuvant-delivery system
- (2014) Ning Wang et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- N-Tetradecylcarbamyl Lipopeptides as Novel Agonists for Toll-like Receptor 2
- (2014) Marian M. J. H. P. Willems et al. JOURNAL OF MEDICINAL CHEMISTRY
- T-Cell and NK-Cell Infiltration into Solid Tumors: A Key Limiting Factor for Efficacious Cancer Immunotherapy
- (2014) I. Melero et al. Cancer Discovery
- The Role of the Helper Lipid on the DNA Transfection Efficiency of Lipopolyplex Formulations
- (2014) Zixiu Du et al. Scientific Reports
- A phase IB study on intravenous synthetic mRNA electroporated dendritic cell immunotherapy in pretreated advanced melanoma patients
- (2013) S. Wilgenhof et al. ANNALS OF ONCOLOGY
- TLR4 is essential for dendritic cell activation and anti-tumor T-cell response enhancement by DAMPs released from chemically stressed cancer cells
- (2013) Hongliang Fang et al. Cellular & Molecular Immunology
- Pharmacokinetics and Pharmacokinetic–Pharmacodynamic Correlations of Therapeutic Peptides
- (2013) Lei Diao et al. CLINICAL PHARMACOKINETICS
- Dendritic cells process synthetic long peptides better than whole protein, improving antigen presentation and T-cell activation
- (2013) Rodney A. Rosalia et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- The tumor microenvironment at a glance
- (2013) F. R. Balkwill et al. JOURNAL OF CELL SCIENCE
- HPV16 synthetic long peptide (HPV16-SLP) vaccination therapy of patients with advanced or recurrent HPV16-induced gynecological carcinoma, a phase II trial
- (2013) Mariette I E van Poelgeest et al. Journal of Translational Medicine
- Trastuzumab mediates antibody-dependent cell-mediated cytotoxicity and phagocytosis to the same extent in both adjuvant and metastatic HER2/neu breast cancer patients
- (2013) Branka Petricevic et al. Journal of Translational Medicine
- Synthetic DNA Vaccines: Improved Vaccine Potency by Electroporation and Co-Delivered Genetic Adjuvants
- (2013) Seleeke Flingai et al. Frontiers in Immunology
- Effects of conventional therapeutic interventions on the number and function of regulatory T cells
- (2013) Mario Roselli et al. OncoImmunology
- The tumour suppressor Fhit positively regulates MHC class I expression on cancer cells
- (2012) Irene Romero et al. JOURNAL OF PATHOLOGY
- Signal 3 Cytokines as Modulators of Primary Immune Responses during Infections: The Interplay of Type I IFN and IL-12 in CD8 T Cell Responses
- (2012) Selina Jessica Keppler et al. PLoS One
- DEC-205 is a cell surface receptor for CpG oligonucleotides
- (2012) M. H. Lahoud et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Role of XCR1 and its Ligand XCL1 in Antigen Cross-Presentation by Murine and Human Dendritic Cells
- (2012) Richard A. Kroczek et al. Frontiers in Immunology
- The Present and Future of Peptide Vaccines for Cancer
- (2011) Craig L. Slingluff CANCER JOURNAL
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Suppression of tumour-specific CD4+T cells by regulatory T cells is associated with progression of human colorectal cancer
- (2011) Gareth Betts et al. GUT
- Functional classification of class II human leukocyte antigen (HLA) molecules reveals seven different supertypes and a surprising degree of repertoire sharing across supertypes
- (2011) Jason Greenbaum et al. IMMUNOGENETICS
- Enzymatically degradable nanogels by inverse miniemulsion copolymerization of acrylamide with dextran methacrylates as crosslinkers
- (2011) Daniel Klinger et al. Polymer Chemistry
- Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier
- (2011) Hirenkumar K. Makadia et al. Polymers
- Antitumor cytotoxic T-cell response induced by a survivin peptide mimic
- (2010) Michael J. Ciesielski et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Inflammatory cytokines as a third signal for T cell activation
- (2010) Julie M Curtsinger et al. CURRENT OPINION IN IMMUNOLOGY
- MHC Class II epitope predictive algorithms
- (2010) Morten Nielsen et al. IMMUNOLOGY
- Naive tumor-specific CD4+T cells differentiated in vivo eradicate established melanoma
- (2010) Ying Xie et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Tumor-reactive CD4+T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts
- (2010) Sergio A. Quezada et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Characteristics of severe adverse events after peptide vaccination for advanced cancer patients: Analysis of 500 cases
- (2010) Yamada ONCOLOGY REPORTS
- CD4 and CD8 binding to MHC molecules primarily acts to enhance Lck delivery
- (2010) M. N. Artyomov et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Induction of p53-Specific Immunity by a p53 Synthetic Long Peptide Vaccine in Patients Treated for Metastatic Colorectal Cancer
- (2009) F. M. Speetjens et al. CLINICAL CANCER RESEARCH
- Selective Expression of the Chemokine Receptor XCR1 on Cross-presenting Dendritic Cells Determines Cooperation with CD8+ T Cells
- (2009) Brigitte G. Dorner et al. IMMUNITY
- The significance of OX40 and OX40L to T-cell biology and immune disease
- (2009) Michael Croft et al. IMMUNOLOGICAL REVIEWS
- Comparing Pooled Peptides with Intact Protein for Accessing Cross-presentation Pathways for Protective CD8+and CD4+T Cells
- (2009) Hongwei Zhang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- CD205 (DEC-205): A recognition receptor for apoptotic and necrotic self
- (2009) Rachel E. Shrimpton et al. MOLECULAR IMMUNOLOGY
- Superior induction of anti-tumor CTL immunity by extended peptide vaccines involves prolonged, DC-focused antigen presentation
- (2008) Martijn S. Bijker et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Liposomal vasoactive intestinal peptide for lung application: Protection from proteolytic degradation
- (2008) B STARK et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- The tumor microenvironment and its role in promoting tumor growth
- (2008) T L Whiteside ONCOGENE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now